- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
FDA clears Lutronic’s AccuSculpt for laser-assisted lipolysis
Princeton Junction, N.J. - Lutronic has announced Food and Drug Administration clearance for their laser-assisted lipolysis system AccuSculpt, according to a company press release.
Princeton Junction, N.J.
- Lutronic has announced Food and Drug Administration clearance for their laser-assisted lipolysis system AccuSculpt, according to a company press release.
The system is also indicated for the surgical incision, excision, vaporization, ablation and coagulation of soft tissue, according to the release, and for is the first and only pulsed Nd:YAG laser to deliver 1,444 nm wavelength for minimally invasive deep tissue heating.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
